This is a contract modification for a settlement termination at no cost. It incorporates a standard FAR clause prohibiting a specific application. The contract includes invoked option years covering performance from April 5, 2022, through April 4, 2024. The original solicitation was for Fenofibrate Nanocrystalize Tablets.

The Defense Logistics Agency plans a national requirements contract for Fenofibrate Nanocrystalize Tablets (48MG and 145MG in 90-count bottles) for DoD, VA, Indian Health Service, and Bureau of Prisons customers. It will be a firm-fixed price contract with a one-year base period and four one-year option periods. The solicitation is projected for September 2020, though the agency reserves the right to issue it before or after that date. The contract is unrestricted, fully competitive, and for a commercial item. Interested parties should monitor the DLA Bid Board System and Beta SAM.gov for the official solicitation.